Brief: iX Biopharma To Dispose Laboratory Testing Business For A$12.5 Mln
18/02/2019 24:51
Feb 18 (Reuters) - iX Biopharma Ltd IXBI.SI :
* IX BIOPHARMA ANNOUNCES PROPOSED DISPOSAL OF LABORATORY
TESTING
BUSINESS
* CONSIDERATION FOR PROPOSED DISPOSAL IS A$12.5 MILLION
* NET GAIN ON DISPOSAL IS ABOUT S$10.4 MILLION
Source text for Eikon: urn:newsml:reuters.com:*:nSNZ993HW8
Further company coverage: IXBI.SI
((Reuters.Briefs@thomsonreuters.com;))
Recent news on IX Biopharma
See all newsBrief: IX Biopharma Says Co Will Undertake An Internal Restructuring Of Its Consumer Business
Brief: IX Biopharma To Issue 1 MLN New Shares To Anson Properties At S$0.4215 Per Share
Brief: IX Biopharma Says US Government Awards US$41 MLN Contract To Fund Development Of Wafermine
Brief: IX Biopharma To Raise At Least S$6 MLN Via Placement At S$0.198 Per Share
Brief: IX Biopharma Enters Term Sheet For Proposed Joint Venture